Bio Green Med Solution (BGMS) Other Non-Current Liabilities (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Other Non-Current Liabilities of $8000.0 for Q1 2026, down 11.11% quarter-over-quarter from $9000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Other Non-Current Liabilities for 11 consecutive years, with $8000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $8000.0; the TTM figure through Mar 2026 stood at $8000.0 (changed N/A YoY), while the FY2025 annual figure was $9000.0, changed N/A from the prior year.
- Other Non-Current Liabilities eased to $8000.0 in Q1 2026 per BGMS's latest filing, from $9000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $55000.0 in Q3 2025 and bottomed at $8000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.45 Bn | 132.60 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.92 Bn | 78.93 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.65 Bn | 59.47 Bn | 1.37 Bn |
| 4 | Moderna | 58.28 Bn | 53.14 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 40.12 Bn | 35.02 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.83 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 27.93 Bn | 27.10 Bn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 5.04 Mn | 1.25 Mn | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Dec 31, 2018 | 100,000.00 |
| Dec 31, 2017 | 124,000.00 |
| Dec 31, 2016 | 130,000.00 |
| Mar 31, 2016 | 166,000.00 |
| Dec 31, 2015 | 176,000.00 |
| Sep 30, 2015 | 186,000.00 |
| Jun 30, 2015 | 198,000.00 |
| Mar 31, 2015 | 192,000.00 |
| Dec 31, 2014 | 206,000.00 |
| Sep 30, 2014 | 221,000.00 |
| Jun 30, 2014 | 238,000.00 |
| Dec 31, 2013 | 241,000.00 |
| Sep 30, 2013 | 20,000.00 |
| Mar 31, 2013 | 550,000.00 |
| Dec 31, 2012 | 1.12 Mn |
| Sep 30, 2012 | 1.07 Mn |